We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Wants Pediatric Trial Plans to Reflect Drug Delivery Options
EC Wants Pediatric Trial Plans to Reflect Drug Delivery Options
November 11, 2013
When adding a pediatric indication to a drug product, drugmakers are advised to consider a range of different pharmaceutical forms and formulations that might be more suitable for children, a draft revision to European Commission guidelines on pediatric investigation plans says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor